Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
94.1M
-
Shares change
-
+4.65M
-
Total reported value, excl. options
-
$11.8B
-
Value change
-
+$583M
-
Put/Call ratio
-
0.61
-
Number of buys
-
162
-
Number of sells
-
-190
-
Price
-
$125.01
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2021
463 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2021.
Guardant Health, Inc. - Common Stock (GH) has 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.1M shares
of 124M outstanding shares and own 76% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.7M shares), FMR LLC (6.41M shares), MORGAN STANLEY (5.56M shares), BlackRock Inc. (5.56M shares), Capital Research Global Investors (5.29M shares), VIKING GLOBAL INVESTORS LP (4.89M shares), Clearbridge Investments, LLC (3.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.16M shares), COATUE MANAGEMENT LLC (2.81M shares), and FRED ALGER MANAGEMENT, LLC (2.66M shares).
This table shows the top 365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.